Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × Granulocyte Colony-Stimulating Factor × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Myelodysplastic Syndromes 17 Lymphoma, Non-Hodgkin 9 Multiple Myeloma 8 Leukemia, Biphenotypic, Acute 8 Hodgkin Disease 8 Leukemia 7 Burkitt Lymphoma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Recurrence 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Hematologic Neoplasms 5 Anemia, Refractory, with Excess of Blasts 5 Myeloproliferative Disorders 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myelomonocytic, Chronic 4 Breast Neoplasms 4 Neuroblastoma 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Rhabdomyosarcoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Medulloblastoma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myelomonocytic, Juvenile 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Dexamethasone 11 daratumumab 6 Bortezomib 6 Cyclophosphamide 5 venetoclax 3 ixazomib 3 belantamab mafodotin 3 Specimen Handling 3 Focal Adhesion Protein-Tyrosine Kinases 3 Calcium Dobesilate 3 pomalidomide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 X-Rays 2 Polymerase Chain Reaction 2 Phantoms, Imaging 2 Magnetic Resonance Spectroscopy 2 Clinical Protocols 2 Biopsy 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 siltuximab 1 isatuximab 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Spectrometry, Fluorescence 1 Positron-Emission Tomography 1 Pharmaceutical Preparations 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡